vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与Laird Superfood, Inc.（LSF）财务数据对比。点击上方公司名可切换其他公司
CUMBERLAND PHARMACEUTICALS INC的季度营收约是Laird Superfood, Inc.的1.0倍（$13.7M vs $13.3M），CUMBERLAND PHARMACEUTICALS INC净利率更高（-10.3% vs -13.2%，领先2.9%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs 15.0%），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs 16.1%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
Laird Superfood是一家主营植物基功能性超级食品的企业，产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等，面向健康意识较强的消费群体，主要在北美市场通过电商及线下零售渠道销售，主打可持续采购的清洁配方。
CPIX vs LSF — 直观对比
营收规模更大
CPIX
是对方的1.0倍
$13.3M
营收增速更快
CPIX
高出16.1%
15.0%
净利率更高
CPIX
高出2.9%
-13.2%
两年增速更快
CPIX
近两年复合增速
16.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $13.3M |
| 净利润 | $-1.4M | $-1.8M |
| 毛利率 | 83.6% | 34.1% |
| 营业利润率 | -10.0% | -13.5% |
| 净利率 | -10.3% | -13.2% |
| 营收同比 | 31.1% | 15.0% |
| 净利润同比 | 25.8% | -341.4% |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXLSF
| Q4 25 | $13.7M | $13.3M | ||
| Q3 25 | $8.3M | $12.9M | ||
| Q2 25 | $10.8M | $12.0M | ||
| Q1 25 | $11.7M | $11.7M | ||
| Q4 24 | $10.4M | $11.6M | ||
| Q3 24 | $9.1M | $11.8M | ||
| Q2 24 | $9.8M | $10.0M | ||
| Q1 24 | $8.5M | $9.9M |
净利润CPIXLSF
| Q4 25 | $-1.4M | $-1.8M | ||
| Q3 25 | $-1.9M | $-975.1K | ||
| Q2 25 | $-740.7K | $-362.2K | ||
| Q1 25 | $1.3M | $-156.2K | ||
| Q4 24 | $-1.9M | $-398.4K | ||
| Q3 24 | $-1.5M | $-166.1K | ||
| Q2 24 | $-1.1M | $-239.1K | ||
| Q1 24 | $-1.9M | $-1.0M |
毛利率CPIXLSF
| Q4 25 | 83.6% | 34.1% | ||
| Q3 25 | 88.1% | 36.5% | ||
| Q2 25 | 81.4% | 39.9% | ||
| Q1 25 | 87.8% | 41.9% | ||
| Q4 24 | 81.1% | 38.6% | ||
| Q3 24 | 85.4% | 43.0% | ||
| Q2 24 | 82.6% | 41.8% | ||
| Q1 24 | 81.5% | 40.0% |
营业利润率CPIXLSF
| Q4 25 | -10.0% | -13.5% | ||
| Q3 25 | -23.7% | -7.7% | ||
| Q2 25 | -6.9% | -3.3% | ||
| Q1 25 | 11.0% | -1.9% | ||
| Q4 24 | -17.7% | -4.1% | ||
| Q3 24 | -18.6% | -2.3% | ||
| Q2 24 | -10.4% | -3.4% | ||
| Q1 24 | -22.0% | -11.0% |
净利率CPIXLSF
| Q4 25 | -10.3% | -13.2% | ||
| Q3 25 | -23.4% | -7.6% | ||
| Q2 25 | -6.8% | -3.0% | ||
| Q1 25 | 10.7% | -1.3% | ||
| Q4 24 | -18.2% | -3.4% | ||
| Q3 24 | -17.0% | -1.4% | ||
| Q2 24 | -11.0% | -2.4% | ||
| Q1 24 | -22.9% | -10.3% |
每股收益（稀释后）CPIXLSF
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $-0.13 | — | ||
| Q2 25 | $-0.05 | — | ||
| Q1 25 | $0.08 | — | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | $-0.11 | — | ||
| Q2 24 | $-0.08 | — | ||
| Q1 24 | $-0.14 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $5.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $24.9M | $11.5M |
| 总资产 | $76.8M | $19.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPIXLSF
| Q4 25 | $11.4M | $5.1M | ||
| Q3 25 | $15.2M | $5.1M | ||
| Q2 25 | $16.1M | $3.9M | ||
| Q1 25 | $15.1M | $7.0M | ||
| Q4 24 | $18.0M | $8.3M | ||
| Q3 24 | $17.5M | $7.9M | ||
| Q2 24 | $17.3M | $7.6M | ||
| Q1 24 | $18.5M | $7.1M |
股东权益CPIXLSF
| Q4 25 | $24.9M | $11.5M | ||
| Q3 25 | $26.1M | $12.8M | ||
| Q2 25 | $28.0M | $13.4M | ||
| Q1 25 | $28.7M | $13.3M | ||
| Q4 24 | $22.9M | $13.2M | ||
| Q3 24 | $24.8M | $13.1M | ||
| Q2 24 | $26.3M | $12.6M | ||
| Q1 24 | $27.5M | $12.7M |
总资产CPIXLSF
| Q4 25 | $76.8M | $19.2M | ||
| Q3 25 | $65.9M | $18.9M | ||
| Q2 25 | $67.9M | $20.4M | ||
| Q1 25 | $69.9M | $21.5M | ||
| Q4 24 | $75.6M | $19.3M | ||
| Q3 24 | $76.7M | $18.8M | ||
| Q2 24 | $78.5M | $18.0M | ||
| Q1 24 | $81.5M | $17.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $68.4K |
| 自由现金流经营现金流 - 资本支出 | $3.0K | — |
| 自由现金流率自由现金流/营收 | 0.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.8M | — |
8季度趋势，按日历期对齐
经营现金流CPIXLSF
| Q4 25 | $3.0K | $68.4K | ||
| Q3 25 | $187.2K | $1.2M | ||
| Q2 25 | $843.8K | $-2.8M | ||
| Q1 25 | $3.9M | $-1.3M | ||
| Q4 24 | $1.9M | $339.2K | ||
| Q3 24 | $475.5K | $305.8K | ||
| Q2 24 | $-855.7K | $642.7K | ||
| Q1 24 | $-2.1M | $-422.3K |
自由现金流CPIXLSF
| Q4 25 | $3.0K | — | ||
| Q3 25 | $163.4K | — | ||
| Q2 25 | $817.3K | — | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $460.1K | — | ||
| Q2 24 | $-862.8K | — | ||
| Q1 24 | $-2.2M | — |
自由现金流率CPIXLSF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 32.9% | — | ||
| Q4 24 | 18.2% | — | ||
| Q3 24 | 5.1% | — | ||
| Q2 24 | -8.8% | — | ||
| Q1 24 | -25.6% | — |
资本支出强度CPIXLSF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.5% | — |
现金转化率CPIXLSF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPIX
暂无分部数据
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
